Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis
- 8 February 2004
- Vol. 22 (13-14) , 1609-1615
- https://doi.org/10.1016/j.vaccine.2003.09.044
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Intranasal Gene Transfer by Chitosan–DNA Nanospheres Protects BALB/c Mice Against Acute Respiratory Syncytial Virus InfectionHuman Gene Therapy, 2002
- Chitosans for gene deliveryAdvanced Drug Delivery Reviews, 2001
- Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivoGene Therapy, 2001
- Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine AntigensInfection and Immunity, 2000
- Bronchus-Associated Lymphoid Tissue (BALT) Is Not Present in the Normal Adult Lung but in Different DiseasesPathobiology, 2000
- Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitroImmunology, 1996
- An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.The Journal of Experimental Medicine, 1993
- Immunity to Intracellular BacteriaAnnual Review of Immunology, 1993
- Mycobacterial‐induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patientsEuropean Journal of Immunology, 1990
- Aerogenic vaccination of mice with mycobacterium bovis BCGTubercle, 1986